In a large single-center cohort, high risk CMV mismatch was associated with increased CMV viremia and a nonsignificant trend towards increased graft loss with belatacept compared to tacrolimus-based immunosuppression.
1
—
—
In a large single-center cohort, high risk CMV mismatch was associated with increased CMV viremia and a nonsignificant trend towards increased graft loss with belatacept compared to tacrolimus-based immunosuppression.